Works Cited

1. U.S. Census Bureau. Americans with Disabilities: 2014. Available at https://www.census.gov/content/dam/Census/library/publications/2018/demo/p70-152.pdf. Last accessed February 22, 2019.

2. Administration on Aging. 2017 Profile of Older Americans. Available at https://acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2017OlderAmericansProfile.pdf. Last accessed February 22, 2019.

3. Sjögren's Syndrome Foundation. Diagnosis. Available at https://www.sjogrens.org/home/about-sjogrens/diagnosis. Last accessed February 22, 2019.

4. Miller AV, Francis ML, Pema K, Ranatunga SKM, Tumyan A. Sjögren Syndrome. Available at https://emedicine.medscape.com/article/332125-overview. Last accessed February 22, 2019.

5. Casiglia JM, Mirowski GW. Oral Manifestations of Systemic Diseases. Available at https://emedicine.medscape.com/article/1081029-overview. Last accessed February 24, 2019.

6. Radke LM. Pre-radiation therapy dental evaluation. Greater Milwaukee Dental Association Journal. 1996;63(4):104-109.

7. American Dental Association. Managing Xerostomia and Salivary Gland Hypofunction: A Report of the ADA Council on Scientific Affairs. Available at http://www.ada.org/~/media/ADA/Science%20and%20Research/Files/CSA_Managing_Xerostomia.pdf. Last accessed February 24, 2019.

8. Yan Z, Young AL, Hua H, Xu Y. Multiple oral Candida infections in patients with Sjögren's syndrome: prevalence and clinical drug susceptibility profiles. J Rheumatol. 2011;38(11):2428-2431.

9. Little JW, Miller CS, Rhodus NL. Little and Falace'sDental Management of the Medically Compromised Patient. 9th ed. St. Louis, MO: Mosby; 2017.

10. Laudenbach JM, Ship JA. Clinician's Guide to Oral Health in Geriatric Patients. 3rd ed. Edmonds, WA: American Academy of Oral Medicine; 2011.

11. Jonsson R, Vogelsang P, Volchenkov R, Espinosa A, Wahren-Herlenius M, Appel S. The complexity of Sjögren's syndrome: novel aspects of pathogenesis. Immunol Lett. 2011;141(1):1-9.

12. González S, Sung H, Sepúlveda D, González M, Molina C. Oral manifestations and their treatment in Sjögren's syndrome.Oral Dis. 2014;20(2):153-161.

13. Rekvig OP, Van der Vlag J. The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved. Semin Immunopathol. 2014;36(3):301-311.

14. Scully C, Flint SR, Bagan JV, Porter SR, Moos KF. Oral and Maxillofacial Diseases: An Illustrated Guide to Diagnosis and Management of Diseases of the Oral Mucosa, Gingivae, Teeth, Salivary Glands, Bones, and Joints. 4th ed. London: Informa Healthcare; 2010.

15. Weckerle CE, Niewold TB. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol. 2011;40(1):42-49.

16. Hersh AO, Trupin L, Yazdany J, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2010;62(8):1152-1159.

17. Souza DCC, Santo AH, Sato EI. Mortality profile related to systemic lupus erythematosus: a multiple cause-of-death analysis.J Rheumatol. 2012;39(3):496-503.

18. Thomas G, Mancini J, Jourde-Chiche N, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol. 2014;66(9):2503-2511.

19. Petri M. Life-threatening complications of systemic lupus erythematosus. In: Khamashta MA, Ramos-Casals M (eds). Autoimmune Diseases: Acute and Complex Situations. London: Springer-Verlag; 2011: 9-17.

20. American Dental Association. American Dental Association Guide to Dental Therapeutics. 5th ed. Chicago, IL: American Dental Association; 2009.

21. Wynn RL, Meiller TF, Crossley HL. Drug Information Handbook for Dentistry. 24th ed. Hudson, OH: Lexi-Comp; 2018.

22. RxList. Cytoxan. Available at https://www.rxlist.com/cytoxan-drug.htm. Last accessed February 26, 2019.

23. Shetti A, Gupta I, Charantimath SM. Oral candidiasis: aiding in the diagnosis of HIV: a case report. Case Rep Dent. 2011;929616.

24. New York State Department of Health and AIDS Institute. Promoting Oral Health Care for People with HIV Infection. Available at http://nationalqualitycenter.org/files/promoting-oral-health-care-for-people-with-hiv-infection/. Last accessed February 26, 2019.

25. Scully C. Medical Problems in Dentistry. 7th ed. Edinburgh: Churchill Livingstone Elsevier; 2014.

26. Suzuki JB, Chialastri SM. Dental implications for the immunocompromised organ transplant patient. Grand Rounds in Oral-Systemic Medicine. 2007;2(3):36-44.

27. Boltchi FE, Rees TD, Iacopino AM. Cyclosporine A-induced gingival overgrowth: a comprehensive review. Quintessence Int. 1999;30(11):775-783.

28. LexiComp Online. Available at http://online.lexi.com. Last accessed February 26, 2019.

29. Muñoz P, Giannella M, Burillo A, Bouza E. Aspergillus and other mold infections after solid organ transplant. In: Bowden RA, Ljungman P, Snydman DR (eds). Transplant Infections. 3rd ed. China: Lippincott Williams & Wilkins; 2012: 554-585.

30. Centers for Disease Control and Prevention. Fungal Diseases: Treatment for Aspergillosis. Available at https://www.cdc.gov/fungal/diseases/aspergillosis/treatment.html. Last accessed February 26, 2019.

31. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantation. Cancer. 2013;119(12):2300-2308.

32. Tessari G, Naldi L, Boschiero L, et al. Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study. Arch Dermatol. 2010;146(3):294-299.

33. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United States. Am J Transplant. 2013;13(12):3202-3209.

34. Rhodus NL, Little JW. Dental management of the bone marrow transplant patient. Compendium. 1992;13(11):1040, 1042-1050.

35. Newman MG, van Winkelhoff AJ. Antibiotic and Antimicrobial Use in Dental Practice. 2nd ed. Carol Stream, IL: Quintessence Publishing Co Inc.; 2001.

36. Organ Procurement and Transplantation Network. Special Issue: OPTN/SRTR Annual Data Report 2014. Am J Transplant. 2016;16(Suppl S2):4-215.

37. DeMaagd G, Philip A. Parkinson's disease and its management. Part 1: disease entity, risk factors, pathophysiology, clinical presentation, and diagnosis. PT. 2015;40(8):504-510, 532.

38. Schapira AH. Treatment options in the modern management of Parkinson disease. Arch Neurol. 2007;64(8):1083-1088.

39. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality—1967. Neurology. 1998;50(2):318-334.

40. Kalf JG, de Swart BJ, Borm GF, Bloem BR, Munneke M. Prevalence and definition of drooling in Parkinson's disease: a systematic review. J Neurol. 2009;256(9):1391-1396.

41. Korchounov A, Kessler KR, Schipper HI. Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's disease. Acta Neurol Scand. 2004;109(1):45-51.

42. CerebralPalsy.org. Prevalence and Incidence of Cerebral Palsy. Available at https://www.cerebralpalsy.org/about-cerebral-palsy/prevalence-and-incidence. Last accessed February 27, 2019.

43. Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy, April 2006. Dev Med Child Neurol Suppl. 2007;109:8-14.

44. Sehrawat N, Marwaha M, Bansal K, Chopra R. Cerebral palsy: a dental update. Int J Clin Pediatr Dent. 2014;7(2):109-118.

45. National Spinal Cord Injury Statistical Center. Spinal Cord Injury Facts and Figures At A Glance, 2018. Available at https://www.nscisc.uab.edu/Public/Facts%20and%20Figures%20-%202018.pdf. Last accessed February 27, 2019.

46. University of Florida College of Dentistry. Oral Care for Persons with Disabilities: Traumatic Injuries. Available at https://paul-burtner.dental.ufl.edu/oral-health-care-for-persons-with-disabilities/disabling-conditions/traumatic-injuries/. Last accessed February 27, 2019.

47. Tran P, Mannen J. Improving oral healthcare: improving the quality of life for patients after a stroke. Spec Care Dentist. 2009;29(5):218-221.

48. Benjamin EJ, Muntner P, Alonso A, et al. Heart disease and stroke statistics—2019 update: a report from the American Heart Association. Circulation. 2019;139:e1-e473.

49. National Center for Health Statistics. Leading Causes of Death. Available at https://www.cdc.gov/nchs/fastats/leading-causes-of-death.htm. Last accessed February 27, 2019.

50. Henry RG, Smith BJ. Managing older patients who have neurologic disease: Alzheimer disease and cerebrovascular accident.Dent Clin N Am. 2009;53(2):269-294.

51. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008;4(1):145-154.

52. Napenas JJ, Hong CHL, Brennan MT, Furney SL, Fox PC, Lockhart PB. The frequency of bleeding complications after invasive dental treatment in patients receiving single and dual antiplatelet therapy. J Am Dent Assoc. 2009;140(6):690-695.

53. American Dental Association. Anticoagulant and Antiplatelet Medications and Dental Procedures. Available at https://www.ada.org/en/member-center/oral-health-topics/anticoagulant-antiplatelet-medications-and-dental-. Last accessed February 27, 2019.

54. Gulati G, Hevelow M, George M, Behling E, Siegel J. International normalized ratio versus plasma levels of coagulation factors in patients on vitamin K antagonist therapy. Arch Pathol Lab Med. 2011;135(4):490-494.

55. Powell-Hamilton NN. Down Syndrome (Trisomy 21; Trisomy G). Available at https://www.merckmanuals.com/professional/pediatrics/chromosome-and-gene-anomalies/down-syndrome-trisomy-21. Last accessed February 27, 2019.

56. National Down Syndrome Society. Down Syndrome Facts. Available at https://www.ndss.org/about-down-syndrome/down-syndrome-facts/. Last accessed February 27, 2019.

57. National Institute of Dental and Craniofacial Research. Practical Oral Care for People with Down Syndrome. Available at https://www.nidcr.nih.gov/practical-oral-care-people-down-syndrome. Last accessed February 27, 2019.

58. Cheng RHW, Yiu CKY, Leung WK. Oral health in individuals with Down syndrome. In: Dey S (ed). Prenatal Diagnosis and Screening for Down Syndrome. Rijeka: InTech; 2011: 59-76.

59. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa I. Defective neutrophil chemotaxis in Down's syndrome patients and its relationship to periodontal destruction. J Periodontol. 1989;60(5):238-242.

60. Khocht A. Down syndrome and periodontal disease. In: Dey S (ed). Genetics and Etiology of Down Syndrome. Rijeka: InTech;209-230.

61. Yavuzyilmaz E, Ersoy F, Sanal O, Tezcan I, Erçal D. Neutrophil chemotaxis and periodontal status in Down's syndrome patients.J Nihon Univ Sch Dent. 1993;35(2):91-95.

62. Whittingham S, Pitt DB, Sharma DL, Mackay IR. Stress deficiency of the T-lymphocyte system exemplified by Down syndrome. Lancet. 1977;1(8004):163-166.

63. Bagić I, Verzak Z, Cuković-Cavka S, Brkić H, Susić M. Periodontal conditions in individuals with Down's syndrome. Coll Antropol. 2003;27(Suppl 2):75-82.

64. Hennequin M, Faulks D, Veyrune JL, Bourdiol P. Significance of oral health in persons with Down syndrome: a literature review. Dev Med Child Neurol. 1999;41(4):275-283.

65. Alzheimer's Association. Alzheimer's Facts and Figures. Available at https://www.alz.org/alzheimers-dementia/facts-figures. Last accessed February 27, 2019.

66. Alzheimer's Association. 2018 Alzheimer's disease facts and figures. Alzheimers Dement. 2018;14(3):367-429.

67. Alzheimer's Association. What is Alzheimer's? Available at https://www.alz.org/alzheimers-dementia/what-is-alzheimers. Last accessed February 27, 2019.

68. Seely WW, Miller B. Alzheimer's disease and other dementias. In: Hauser SL, Josephson SA (eds). Harrison's Neurology in Clinical Medicine. 4th ed. New York, NY: McGraw-Hill; 2017: 392-407.

69. Sloane PD, Kaufer DI. Alzheimer's disease. In: Kellerman RD, Rakel D (eds). Conn's Current Therapy 2019. Philadelphia, PA: Elsevier; 2019: 673-677.

70. Tektonidou MG, Lewandowski LB, Dasgupta A, Ward MM. Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016. Ann Rheum Dis. 2017;76(12):2009-2016.

71. Robinson RG, Jorge RE. Post-stroke depression: a review. Am J Psychiatry. 2016;173(3):221-231.

Evidence-Based Practice Recommendations Citations

1. HealthPartners Dental Group and Clinics. Caries Guideline. Minneapolis, MN: HealthPartners Dental Group; 2013. Summary retrieved from Guideline Central at https://www.guidelinecentral.com/summaries/healthpartners-dental-group-and-clinics-caries-guideline. Last accessed April 8, 2019.

2. Cartledge J, Freedman A. Candidiasis. In: British HIV Association and British Infection Association guidelines for the treatment of opportunistic infection in HIV-seropositive individuals, 2011. HIV Med. 2011;12(Suppl 2):70-74. Available at https://www.bhiva.org/file/SwhaEzgXmAGOt/hiv_v12_is2_Iss2Press_Text.pdf. Last accessed April 8, 2019.

3. Johnson VB. Evidence-based practice guideline: oral hygiene care for functionally dependent and cognitively impaired older adults.J Gerontol Nurs. 2012;38(11):11-19. Available at https://www.healio.com/nursing/journals/jgn/2012-11-38-11/{8ba20fd4-6317-4bc8-9695-f81f1abea6db}. Last accessed April 8, 2019.



Privacy Policy
Copyright © 2019 CE Resource, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.